Upvote
Downvote
Director Myeloma Disease Lead Translational Medicine
Share Job
- Suggest Revision
- Bristol Myers Squibb is an integrated global biopharmaceutical company engaged primarily in the discovery, development, and commercialization of novel therapies in the areas of hematology/oncology, cardiovascular and inflammatory diseases through innovative small molecule, biologicals and cell therapy approaches.
- Translational Medicine is part of the Global Research and Early Development organization in BMS and leads mid- to late-stage clinical, pharmacological, and translational research and development activities for the BMS hematology pipeline.
- Translational Medicine Hematology at BMS has a long-standing history of scientific rigor as evidenced by our peer-reviewed publications, delivery of drug approvals including Revlimid, Pomalyst, Idhifa, Inrebic, Onureg and Reblozyl, strong academic collaborations and talent development.
- Our areas of focus include but are not limited to multiple myeloma, acute myeloid leukemia/MDS, lymphoma and erythroid disorders.
- Reporting to the VP, Hematology Translational Medicine Disease Team (TMDT), the incumbent will be responsible for development and execution of disease-centric translational strategies in multiple myeloma to maintain a leadership position for BMS in this key disease area in the future.
Active Job
Updated 8 days agoSimilar Job
Relevance
Active